Silver Book Fact

Prescription eye drops could delay or prevent half of glaucoma cases in African Americans.

Higginbotham, Eve J., Mae O. Gordon, Julie A. Beiser, Michael V. Drake, G. Richard Bennett, M. Roy Wilson, and Michael A. Kass. The Ocular Hypertension Treatment Study: Topical medication delays or prevents primary open-angle glaucoma in African American individuals. Archives of Ophthalmology. 2004; 122(6): 813-20. http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=15197055&dopt=AbstractPlus

Reference

Title
The Ocular Hypertension Treatment Study: Topical medication delays or prevents primary open-angle glaucoma in African American individuals
Publication
Archives of Ophthalmology
Publication Date
2004
Authors
Higginbotham, Eve J., Mae O. Gordon, Julie A. Beiser, Michael V. Drake, G. Richard Bennett, M. Roy Wilson, and Michael A. Kass
Volume & Issue
Volume 122, Issue 6
Pages
813-20
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Multifoca electroretinogram (mFERG) measures show abnormal function of the retina early in–and even prior to–diabetic retinopathy onset and could enhance monitoring of the early stages of disease progression in individuals.  
  • Screening and treatment of diabetic retinopathy in type 2 diabetes patients produces annual savings of $247.9 million to the federal budget– in 1994 dollars.  
  • Timely treatment and follow-up care can reduce the risk of blindness in individuals with proliferative retinopathy by 95%.  
  • Current treatments for proliferative diabetic retinopathy have reduced the rate of blindness within 5 years from 50% to less than 5%.  
  • AMD risk reduction through diet
    A recent study indicated that 20% of AMD cases in the AREDS study would have been eliminated if the participants consumed diets with a dGI (dietary glycemic index) below the…